COVID-19 and Cancer: A Comparison of the Two Important Pandemic Waves in an Indian Cancer Patients' Cohort

Affiliations

Ullas Batra: ORCiD; Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India
Shrinidhi Nathany: Section of Molecular Diagnostics, Department of Pathology, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India
Mansi Sharma: Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India
Sekhar Saha: Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India
Dushyant Kumar: Section of Molecular Diagnostics, Department of Pathology, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India
Joslia T. Jose: Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India
Harkirat Singh: Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India

Abstract

No abstracts available.

ISSN: 2278-330X (Print); 2278-4306 (Online)
Publisher: Thieme Medical and Scientific Publishers Pvt. Ltd.
Country of publisher: India
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://doi.org/10.1055/s-00049561